STAT+: Pharmalittle: We’re reading about GLP-1 use, Covid-19 vaccine investment returns, and more

During July and August 2025, approximately 1 in 10 U.S. adults reported taking a GLP-1 medication during the previous year
This is a brief. The reporting belongs to STAT — read the complete story, with full context and credits, at the source.
Read the full story at STAT ↗statnews.com
More from the Health desk

Democrats settle on a message: ‘Medicare for More’

STAT+: Helus’ psychedelic drug improved depression in study but faces safety questions

Pope Leo wraps up South America tour that tested recovery from cancer surgery
